EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urbanicity and Lyme Disease: 20 Year Trends in Incidence and Case Burden in the United States

Madiha Shafquat iD, L Hannah Gould iD, Patrick H Kelly, Stephanie A Duench iD, James H Stark iD

Public Health Challenges · 2026-12 · 5 (4)

DOI: 10.1002/puh2.70361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Challenges, online erschienen am 06.11.2026. Verfasst von Madiha Shafquat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Global Vaccines Medical Affairs Pfizer New York New York USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Incidence of Lyme disease (LD) has increased over the last few decades in the United States (US). We examined trends in LD incidence and case burden in high‐incidence jurisdictions in the US from 2000 to 2021 by urbanicity. County‐level counts of confirmed LD cases from 2000 to 2021 were obtained from national surveillance data. Incidence rates were calculated using census population projections. Urbanicity was categorized using Rural–Urban Continuum Codes (RUCC). Mixed effects models were used to analyze annual changes in LD incidence. Over 70% of LD cases each year were residents of metro counties. All RUCCs had an incidence greater than 10 LD cases per 100,000 per year from 2001 to 2021. LD incidence significantly increased across all RUCCs, with the largest estimated increases in counties in moderately urban areas. Urban populations have substantially contributed to the overall burden of LD in the US, whereas populations in more moderately urban areas had the largest estimated increases in LD incidence. These findings highlight the need for targeted educational interventions and public health measures across urbanicity levels to address the rising burden of LD in the US.

Schlagwörter

Stichwörter der Autor:innen

Lyme diseasepublic health surveillanceurban health

Autor:innen und Institutionen

  • Global Vaccines Medical Affairs Pfizer New York New York USA.
  • US Medical Affairs, US Commercial Division Pfizer Collegeville Pennsylvania USA.
  • Global Vaccines Medical Affairs Pfizer Cambridge Massachusetts USA.

ORCID-Profile: Madiha Shafquat, L Hannah Gould, Stephanie A Duench, James H Stark

Zitieren

APA

Shafquat, M., Gould, L. H., Kelly, P. H., Duench, S. A., & Stark, J. H. (2026). Urbanicity and Lyme Disease: 20 Year Trends in Incidence and Case Burden in the United States. Public Health Challenges, 5(4). https://doi.org/10.1002/puh2.70361

Vancouver

Shafquat M, Gould LH, Kelly PH, Duench SA, Stark JH. Urbanicity and Lyme Disease: 20 Year Trends in Incidence and Case Burden in the United States. Public Health Challenges. 2026;5(4). doi:10.1002/puh2.70361

BibTeX
@article{Shafquat2026,
  author = {Shafquat, Madiha and Gould, L Hannah and Kelly, Patrick H and Duench, Stephanie A and Stark, James H},
  title = {Urbanicity and Lyme Disease: 20 Year Trends in Incidence and Case Burden in the United States},
  journal = {Public Health Challenges},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1002/puh2.70361}
}
Kostenlos starten →